Showing results (111-120 of 159) with videos related to
Sort By:
Pageof 16
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Treg Depletion-enhanced IL-2 Treatment Facilitates Therapy of Established Tumors Using Systemically Delivered Oncolytic VirusTimothy Kottke, Feorillo Galivo, Phonphimon Wongthida, et al.International Journal of Cancer|November 2, 2012
Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cellsRobert A Adair, Karen J Scott, Sheila Fraser, et al.Journal for Immunotherapy of Cancer|June 9, 2021
On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapyPablo Nenclares, Lucinda Gunn, Heba Soliman, et al.Nature Biotechnology|August 10, 2004
A simple method to cure established tumors by inflammatory killing of normal cellsGregory A Daniels, Luis Sanchez-Perez, Rosa Maria Diaz, et al.Molecular Therapy Oncolytics|March 5, 2020
The PERK Inhibitor GSK2606414 Enhances Reovirus Infection in Head and Neck Squamous Cell Carcinoma via an ATF4-Dependent MechanismMartin McLaughlin, Malin Pedersen, Victoria Roulstone, et al.Cancer Research|March 26, 2002
Strategies for antigen loading of dendritic cells to enhance the antitumor immune responseScott E Strome, Stephen Voss, Ryan Wilcox, et al.Nature Medicine|December 11, 2007
Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapyJian Qiao, Timothy Kottke, Candice Willmon, et al.Cancer Research|March 13, 2024
FUME-TCRseq Enables Sensitive and Accurate Sequencing of the T-cell Receptor from Limited Input of Degraded RNAAnn-Marie Baker, Gayathri Nageswaran, Pablo Nenclares, et al.Molecular Therapy Oncolytics|April 20, 2023
Efficacy of coxsackievirus A21 against drug-resistant neoplastic B cellsMatthew Holmes, Gina B Scott, Samuel Heaton, et al.Research Square|December 4, 2023
Chimerization of the Anti-Viral CD8+ T Cell Response with A Broad Anti-Tumor T Cell Response Reverses Inhibition of Checkpoint Blockade Therapy by Oncolytic VirotherapyRichard Vile, Mason Webb, Jacob van Vloten, et al.Pageof 16